Find clinical trials for Alzheimer's Disease in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near San Francisco, CA, USA:
designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...
Phase 2
Palo Alto, California, United States and 50 other locations
The investigators will study performance on computerized cognitive tasks in healthy participants of different ages to gather normative data for newly...
Berkeley, California, United States
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
San Francisco, California, United States and 109 other locations
and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...
Phase 2
Walnut Creek, California, United States and 101 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...
Phase 3
Palo Alto, California, United States and 120 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
San Francisco, California, United States of America and 246 other locations
Development of novel disease-modifying therapies for Alzheimer's disease (AD) remains of paramount importance. This study ...
Phase 2
Walnut Creek, California, United States and 1 other location
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease...
Phase 3
Oakland, California, United States and 151 other locations
capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 o...
Phase 3
Walnut Creek, California, United States and 228 other locations
study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's...
Phase 2
San Francisco, California, United States and 200 other locations
Clinical trials
Research sites
Resources
Legal